The landscape of dementia analysis has developed dramatically with the advent of innovative biomarkers, including amyloid PET scans, tau imaging, and blood-primarily based exams that could detect Alzheimer's pathology yrs before signs and symptoms emerge. Although these technological improvements depict amazing development in being familiar with ne